SCOPUS 정보 검색 플랫폼

Volumn 84, Issue 9, 2009, Pages 599-600

Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia

(3) Chowdhury, Saeeda a Seropian, Stuart a Marks, Peter W a,b

a YALE CANCER CENTER (United States)

b YALE UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; GEMTUZUMAB OZOGAMICIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SIDE EFFECT; TREATMENT RESPONSE;

ADULT; AGED; AMINOGLYCOSIDES; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AZACITIDINE; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 69549118237 PISSN: 03618609 EISSN: 10968652 Source Type: Journal
DOI: 10.1002/ajh.21478 Document Type: Article

Times cited : (31)

References (5)

1
- 38349194178
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: An evidence-based review
- Oliansky DM, Appelbaum F, Cassileth PA, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myelogenous leukemia in adults: An evidence-based review. Biol Blood Marrow Transplant 2008;14:137-180.
- (2008) Biol Blood Marrow Transplant , vol.14 , pp. 137-180
- Oliansky, D.M.¹ Appelbaum, F.² Cassileth, P.A.³

2
- 17144416476
- Biology and management of relapsed acute myeloid leukemia
- DOI 10.1111/j.1365-2141.2004.05318.x
- Craddock C, Tauro S, Moss P, Grimwade D. Biology and management of relapsed acute myeloid leukaemia. Br J Haematol 2005;129:18-34. (Pubitemid 40524048)
- (2005) British Journal of Haematology , vol.129 , Issue.1 , pp. 18-34
- Craddock, C.¹ Tauro, S.² Moss, P.³ Grimwade, D.⁴

3
- 34548529948
- Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
- DOI 10.1200/JCO.2006.09.4169
- Blum W, Klisovic RB, Hackanson B, et al. Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol 2007; 25:3884-3891. (Pubitemid 47477265)
- (2007) Journal of Clinical Oncology , vol.25 , Issue.25 , pp. 3884-3891
- Blum, W.¹ Klisovic, R.B.² Hackanson, B.³ Liu, Z.⁴ Liu, S.⁵ Devine, H.⁶ Vukosavljevic, T.⁷ Huynh, L.⁸ Lozanski, G.⁹ Kefauver, C.¹⁰ Plass, C.¹¹ Devine, S.M.¹² Heerema, N.A.¹³ Murgo, A.¹⁴ Chan, K.K.¹⁵ Grever, M.R.¹⁶ Byrd, J.C.¹⁷ Marcucci, G.¹⁸

4
- 33845526373
- High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: A prospective study of the alfa group
- DOI 10.1038/sj.leu.2404434, PII 2404434
- Taksin AL, Legrand O, Raffoux E, et al. High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: A prospective study of the alfa group. Leukemia 2007; 21:66-71. (Pubitemid 44921836)
- (2007) Leukemia , vol.21 , Issue.1 , pp. 66-71
- Taksin, A.-L.¹ Legrand, O.² Raffoux, E.³ De Revel, T.⁴ Thomas, X.⁵ Contentin, N.⁶ Bouabdallah, R.⁷ Pautas, C.⁸ Turlure, P.⁹ Reman, O.¹⁰ Gardin, C.¹¹ Varet, B.¹² De Botton, S.¹³ Pousset, F.¹⁴ Farhat, H.¹⁵ Chevret, S.¹⁶ Dombret, H.¹⁷ Castaigne, S.¹⁸

5
- 57049171822
- Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: Results from a pilot trial
- Nand S, Godwin J, Smith S, et al. Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: Results from a pilot trial. Leuk Lymphoma 2008;49:2141-2147.
- (2008) Leuk Lymphoma , vol.49 , pp. 2141-2147
- Nand, S.¹ Godwin, J.² Smith, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.